Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients

A Cuocolo1, S Esposito, M Volpe

  • 1Istituto di Scienze Radiologiche, Facoltà di Medicina, Università di Napoli, Italy.

Insights

Captopril significantly reduced glomerular filtration rate (GFR) in hypertensive patients with renal artery stenosis (RAS), but not in those with essential hypertension (EH). This radionuclide technique helps identify angiotensin II-dependent renovascular hypertension.

Area of Science:

  • Nephrology
  • Nuclear Medicine
  • Cardiology

Background:

  • Hypertension management requires accurate assessment of renal function.
  • Renovascular hypertension (RVH) is often secondary to renal artery stenosis (RAS).
  • Angiotensin II plays a key role in the pathophysiology of RVH.

Purpose of the Study:

  • To investigate the acute effects of captopril on glomerular filtration rate (GFR) in hypertensive patients.
  • To differentiate between RAS and essential hypertension (EH) using a radionuclide technique.
  • To assess the utility of captopril challenge test in identifying angiotensin II-dependent renal changes.

Main Methods:

  • Utilized a radionuclide technique with [99mTc]DTPA and Gates' method to measure total and split GFR.
  • Administered oral captopril (50 mg) to 11 hypertensive patients (5 with RAS, 6 with EH).
  • Determined GFR under control conditions and after captopril administration.

Main Results:

  • Captopril significantly decreased GFR in the stenotic kidneys of RAS patients (p < 0.01) but not in non-stenotic kidneys.
  • Total GFR decreased significantly after captopril in RAS patients (p < 0.05).
  • No significant GFR changes were observed in EH patients after captopril.

Conclusions:

  • Computed radionuclide GFR determination with a captopril test effectively unmasks angiotensin II-dependent renal function.
  • This technique is valuable for clinical identification of patients with renovascular hypertension.
  • The radionuclide method demonstrated good reproducibility for GFR assessment.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...